Highview Capital Management LLC DE Purchases Shares of 1,040 The Cigna Group (NYSE:CI)

Highview Capital Management LLC DE acquired a new stake in shares of The Cigna Group (NYSE:CI - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,040 shares of the health services provider's stock, valued at approximately $287,000.

Other institutional investors also recently added to or reduced their stakes in the company. Sterling Financial Group Inc. acquired a new position in shares of The Cigna Group in the 4th quarter worth approximately $4,367,000. Marks Group Wealth Management Inc boosted its holdings in shares of The Cigna Group by 3,669.7% in the 3rd quarter. Marks Group Wealth Management Inc now owns 24,013 shares of the health services provider's stock worth $8,319,000 after acquiring an additional 23,376 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of The Cigna Group by 3.6% in the 3rd quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider's stock worth $112,216,000 after acquiring an additional 11,228 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. boosted its holdings in shares of The Cigna Group by 1.1% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 75,837 shares of the health services provider's stock worth $20,942,000 after acquiring an additional 858 shares in the last quarter. Finally, Trinity Street Asset Management LLP raised its position in The Cigna Group by 7.1% in the 3rd quarter. Trinity Street Asset Management LLP now owns 81,411 shares of the health services provider's stock worth $28,204,000 after purchasing an additional 5,397 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

The Cigna Group Stock Up 0.9 %

NYSE CI traded up $2.67 on Thursday, reaching $299.90. The company had a trading volume of 1,269,997 shares, compared to its average volume of 1,794,170. The firm has a market capitalization of $83.42 billion, a price-to-earnings ratio of 24.50, a price-to-earnings-growth ratio of 0.97 and a beta of 0.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company's fifty day moving average is $285.65 and its 200-day moving average is $319.92.

The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the business earned $6.79 earnings per share. On average, research analysts forecast that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.01%. This is an increase from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. The Cigna Group's dividend payout ratio is currently 45.75%.

Analysts Set New Price Targets

CI has been the subject of several research analyst reports. StockNews.com upgraded shares of The Cigna Group from a "hold" rating to a "buy" rating in a research report on Wednesday. Wells Fargo & Company dropped their price objective on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 4th. Oppenheimer dropped their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a research report on Friday, January 31st. Cantor Fitzgerald dropped their price objective on shares of The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Finally, Truist Financial dropped their target price on shares of The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a research report on Tuesday, February 4th. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $373.69.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.